Calabrese JR, Durgam S, Satlin A, Vanover KE, et al. Efficacy and Safety of Lumateperone for Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder: A Phase 3 Randomized Placebo-Controlled Trial. Am J Psychiatry 2021;178:1098-1106.
PMID: 34551584